Abstract

BackgroundNon-adherence to conventional DMARDs is an important indicator for the effectiveness of treatment in early arthritis patients. Reported non-adherence rates differ widely, because studies use different adherence measures.ObjectivesThis study compared...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients.
Johanna M W Hazes ... Jan J V Busschbach
Rheumatology (Oxford, England) | VOL. 55
Johanna M W Hazes, et. al.Johanna M W Hazes ... Jan J V Busschbach
27 Jun 2016
The correlation between 4 adherence measurements methods in patients with rheumatoid arthritis using methotrexate.
Renske C F Hebing ... Milou Van Heuckelum
British journal of clinical pharmacology | VOL. 90
Renske C F Hebing, et. al.Renske C F Hebing ... Milou Van Heuckelum
23 Dec 2023
Psychotropic Medication Nonadherence Among United States Latinos: A Comprehensive Literature Review
Dilip V Jeste ... David P Folsom
Psychiatric Services | VOL. 60
Dilip V Jeste, et. al.Dilip V Jeste ... David P Folsom
01 Feb 2009
POS0865 THE CORRELATION BETWEEN FOUR ADHERENCE MEASUREMENTS METHODS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING METHOTREXATE
M T Nurmohamed ... R Hebing
Annals of the Rheumatic Diseases | VOL. 82
M T Nurmohamed, et. al.M T Nurmohamed ... R Hebing
30 May 2023
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers